FRONT PAGE: Penn Study Finds Solid-Tumor Cancer Patients Ineligible For Clinical Trials Receive Immunotherapy At Greater Rates Despite Lack Of Benefits
| | | | | | | | | | | | | | | | | | | | | |

FRONT PAGE: Penn Study Finds Solid-Tumor Cancer Patients Ineligible For Clinical Trials Receive Immunotherapy At Greater Rates Despite Lack Of Benefits

Newswise — PHILADELPHIA — Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania. The study, published in JAMA Oncology, suggests that the…

RESEARCH: Moderate Caffeine Levels Not Linked To Maternal Health Risques
| | | | | | | | | | | | | | | | | | | | | | |

RESEARCH: Moderate Caffeine Levels Not Linked To Maternal Health Risques

Newswise — PHILADELPHIA – Good news for pregnant coffee lovers: Consuming a low amount of caffeine during pregnancy could help to reduce gestational diabetes risk, according to researchers in the Perelman School of Medicine at the University of Pennsylvania and the National Institutes of Health. The findings were published Monday in JAMA Network Open.“While we…

End of content

End of content